Didanosine (ddI)

Didanosine, commonly known as ddI (2',3'-dideoxyinosine), is an antiretroviral medication used in the treatment of HIV/AIDS. It belongs to the class of nucleoside reverse transcriptase inhibitors (NRTIs) and works by interfering with viral replication through mimicking natural cellular nucleosides. Didanosine is a white solid with the chemical formula C₁₀H₁₂N₄O₃.

Key Details:

Name: Didanosine (ddI)

Chemical Formula: C₁₀H₁₂N₄O₃

Description:
Appearance: White crystalline powder.
Mechanism: A purine nucleoside analogue that is converted intracellularly to dideoxyadenosine triphosphate (ddATP). This active metabolite inhibits HIV reverse transcriptase by acting as a chain terminator, thereby preventing the synthesis of viral DNA.

Uses:

• Medical Treatment: Used in combination with other antiretroviral drugs to manage HIV-1 infection.
• Clinical Application: Prescribed as a therapeutic agent for patients with AIDS or individuals who are HIV-positive.

Note: In some industrial contexts, the abbreviation DDI may refer to Dimeryl Diisocyanate. However, in pharmacology and clinical medicine, ddI almost exclusively refers to the antiviral drug Didanosine.

Contact us at: info@sae-group.net